I think that's what it meant. When we are considering anti-diabetes strategies and explaining to the PBO what to do, maybe we will have more data if the witnesses first come here. Then the PBO will have more of a sense from the witnesses about its costing, and can make a better report.
On March 21st, 2017. See this statement in context.